Literature DB >> 27666016

Molecular basis for the formation of ribonucleoprotein complex of Crimean-Congo hemorrhagic fever virus.

Xiaojing Wang1, Baobin Li2, Yu Guo3, Shu Shen4, Liang Zhao1, Peisheng Zhang5, Yuna Sun6, Sen-Fang Sui7, Fei Deng8, Zhiyong Lou9.   

Abstract

Negative-sense single-strand RNA (-ssRNA) viruses comprise a large family of pathogens that cause severe human infectious diseases. All -ssRNA viruses encode a nucleocapsid protein (NP) to encapsidate the viral genome, which, together with polymerase, forms a ribonucleoprotein complex (RNP) that is packaged into virions and acts as the template for viral replication and transcription. In our previous work, we solved the monomeric structure of NP encoded by Crimean-Congo hemorrhagic fever virus (CCHFV), which belongs to the Nairovirus genus within the Bunyaviridae family, and revealed its unusual endonuclease activity. However, the mechanism of CCHFV RNP formation remains unclear, due to the difficulty in reconstructing the oligomeric CCHFV NP-RNA complex. Here, we identified and isolated the oligomeric CCHFV NP-RNA complex that formed in expression cells. Sequencing of RNA extracted from the complex revealed sequence specificity and suggested a potential encapsidation signal facilitating the association between NP and viral genome. A cryo-EM reconstruction revealed the ring-shaped architecture of the CCHFV NP-RNA oligomer, thus defining the interaction between the head and stalk domains that results in NP multimerization. This structure also suggested a modified gating mechanism for viral genome encapsidation, in which both the head and stalk domains participate in RNA binding. This work provides insight into the distinct mechanism underlying CCHFV RNP formation compared to other -ssRNA viruses.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Architecture; CCHFV; Nucleocapsid protein; Oligomer

Mesh:

Substances:

Year:  2016        PMID: 27666016     DOI: 10.1016/j.jsb.2016.09.013

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  6 in total

1.  Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus.

Authors:  Baocheng Liu; Shishang Dong; Guobang Li; Wenming Wang; Xiang Liu; Yantong Wang; Cheng Yang; Zihe Rao; Yu Guo
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  Distinct Mechanism for the Formation of the Ribonucleoprotein Complex of Tomato Spotted Wilt Virus.

Authors:  Yu Guo; Baocheng Liu; Zhenzhen Ding; Guobang Li; Meizi Liu; Dantong Zhu; Yuna Sun; Shishang Dong; Zhiyong Lou
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 3.  Structural and functional similarities in bunyaviruses: Perspectives for pan-bunya antivirals.

Authors:  Sebastiaan Ter Horst; Nádia Conceição-Neto; Johan Neyts; Joana Rocha-Pereira
Journal:  Rev Med Virol       Date:  2019-02-11       Impact factor: 6.989

4.  Purification of Crimean-Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis.

Authors:  Boniface Pongombo Lombe; Hiroko Miyamoto; Takeshi Saito; Reiko Yoshida; Rashid Manzoor; Masahiro Kajihara; Masayuki Shimojima; Shuetsu Fukushi; Shigeru Morikawa; Tomoki Yoshikawa; Takeshi Kurosu; Masayuki Saijo; Qing Tang; Justin Masumu; David Hawman; Heinz Feldmann; Ayato Takada
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

5.  Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV).

Authors:  Elif Karaaslan; Nesibe Selma Çetin; Merve Kalkan-Yazıcı; Sevde Hasanoğlu; Faruk Karakeçili; Aykut Özdarendeli; Ahmet Kalkan; Ali Osman Kılıç; Mehmet Ziya Doymaz
Journal:  PLoS Negl Trop Dis       Date:  2021-12-01

6.  The Native Orthobunyavirus Ribonucleoprotein Possesses a Helical Architecture.

Authors:  Francis R Hopkins; Beatriz Álvarez-Rodríguez; George R Heath; Kyriakoulla Panayi; Samantha Hover; Thomas A Edwards; John N Barr; Juan Fontana
Journal:  mBio       Date:  2022-06-28       Impact factor: 7.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.